% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@INBOOK{Drzezga:911484,
      author       = {Drzezga, Alexander and Bischof, Gérard and Giehl, Kathrin
                      and Eimeren, Thilo van},
      title        = {{PET} and {SPECT} {I}maging of {N}eurodegenerative
                      {D}iseases},
      address      = {Amsterdam},
      publisher    = {Elsevier},
      reportid     = {FZJ-2022-04753},
      pages        = {1309-1334},
      year         = {2021},
      note         = {},
      comment      = {Molecular Imaging: Principles and Practice},
      booktitle     = {Molecular Imaging: Principles and
                       Practice},
      abstract     = {Today, a number of complementary molecular imaging methods
                      are at our disposal, which can make a relevant contribution
                      to early diagnosis, differential diagnosis, disease
                      monitoring, and follow-up of neurodegenerative diseases.
                      This includes long-established FDG-PET which provides
                      valuable information on location and extent of pathology and
                      has demonstrated great value for early diagnosis, short-term
                      prognosis, and for differential diagnosis of various
                      disorders on the basis of the endophenotype of disease.
                      Imaging of the dopaminergic system has proven value in the
                      workup of movement disorders. More recently introduced,
                      amyloid-PET for the first time allows in vivo diagnostic
                      assessment of a molecular neuropathology, most valuable for
                      verification or exclusion of Alzheimer disease (AD),
                      independent of the symptomatic appearance. Finally, new
                      tracers for tau-PET imaging may allow the assessment of
                      location, extent, and specific type of pathology, which may
                      hold great value for early and differential diagnosis of
                      neurodegeneration in the future.},
      cin          = {INM-2},
      cid          = {I:(DE-Juel1)INM-2-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525) / 5253 -
                      Neuroimaging (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252 / G:(DE-HGF)POF4-5253},
      typ          = {PUB:(DE-HGF)7},
      url          = {https://juser.fz-juelich.de/record/911484},
}